Viewing StudyNCT00278187



Ignite Creation Date: 2024-05-05 @ 4:36 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00278187
Status: UNKNOWN
Last Update Posted: 2013-12-19
First Post: 2006-01-16

Brief Title: Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor: Jonsson Comprehensive Cancer Center
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Lung Cancer
Keywords:
Name View
recurrent non-small cell lung cancer View
stage IIIB non-small cell lung cancer View
stage IV non-small cell lung cancer View